SEARCH

SEARCH BY CITATION

References

  • 1
    Magnus, T. and Rao, M. S., Neural stem cells in inflammatory CNS diseases: mechanisms and therapy. J. Cell. Mol. Med. 2005. 9: 303319.
  • 2
    Engelhardt, B. and Ransohoff, R. M., The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005. 26: 485495.
  • 3
    Rebenko-Moll, N. M., Liu, L., Cardona, A. and Ransohoff, R. M., Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr. Opin. Immunol. 2006. 8: 683689.
  • 4
    Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A. et al., Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002. 8: 500508.
  • 5
    Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K. and Iwakura, Y., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 566573.
  • 6
    Weaver, C. T., Hatton, R. D., Mangan, P. R. and Harrington, L. E., IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 2007. 25: 821852.
  • 7
    Bettelli, E., Korn, T., Oukka, M. and Kuchroo, V. K., Induction and effector functions of TH17 cells. Nature 2008. 453: 10511057.
  • 8
    Kohm, A. P., Carpentier, P. A., Anger, H. A. and Miller, S. D., Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 2002. 169: 47124716.
  • 9
    Korn, T., Reddy, J., Gao, W., Betelli, E., Awasthi, A., Petersen, T. R., Backstrom, B. T. et al., Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 2007. 13: 423431.
  • 10
    Matsumoto, Y., Sakuma, H., Kohyama, K. and Park, I. K., Paralysis of CD4+CD25+ regulatory T cell response in chronic autoimmune encephalomyelitis. J. Neuroimmunol. 2007. 187: 4454.
  • 11
    Rot, A. and von Andrian, U. H., Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 2004. 22: 891928.
  • 12
    Ubogu, E. E., Cossoy, M. B. and Ransohoff, R. M., The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 2006. 27: 4855.
  • 13
    Ambrosini, E., Columba-Cabezas, S., Serafini, B., Muscell, A. and Aloisi, F., Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia 2003. 41: 290300.
  • 14
    Kohler, R. E., Caon, A. C., Willenborg, D. O., Clark-Lewis, I. and McColl, S. R., A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system. J. Immunol. 2003. 170: 62986306.
  • 15
    Kleinewietfeld, M., Puentes, F., Borsellino, G., Battistini, L., Rötzschke, O. and Falk, K., CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset. Blood 2005. 105: 28772886.
  • 16
    Varona, R., Cadenas, V., Lozano, M., Moreno-Ortiz, M. C., Kremer, L., Martínez-A, C. and Márquez, G., CCR6 regulates the function of alloreactive and regulatory CD4+ T cells during acute graft-versus-host disease. Leuk. Lymphoma 2006. 47:14691476.
  • 17
    Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17 producing T cells. Immunity 2006. 24: 179189.
  • 18
    Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K., Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 2006. 441: 235238.
  • 19
    Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B. et al., Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008. 29: 113.
  • 20
    Potzl, J., Botteron, C., Tausch, E., Pedre, X., Mueller, A. M., Mannel, D. N. and Lechner, A., Tracing functional antigen-specific CCR6+ Th17 cells after vaccination. PLoS ONE 2008. 3: e2951.
  • 21
    Sorensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S. et al., Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 1999. 103: 807815.
  • 22
    Zhang, X., Koldzic, D. N., Izikson, L., Reddy, J., Nazareno, R. F., Sakaguchi, S., Kuchroo, V. K. and Weiner, H. L., IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol. 2004. 16: 249256.
  • 23
    Kleinschek, M. A., Owyang, A. M., Joyce-Shaikh, B., Langrish, C. L., Chen, Y., Gorman, D. M., Blumenschein, W. M. et al., IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 2007. 204: 161170.
  • 24
    Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744748.
  • 25
    Yamazaki, T., Yang, O. X., Chung, Y., Fukunaga, A., Nurieva, R., Pappu, B., Martin-Orozco, N. et al., CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 2008. 181: 83918401.
  • 26
    O'Connor, R. A., Prendergast, C. T., Sabatos, C.A., Lau, C. W. Z., Leech, M. D., Wraith, D. C. and Anderton, S. M., Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoinmune encephalomyelitis. J. Immunol. 2008. 181: 37503754.
  • 27
    Lochner, M., Peduto, L., Cherrier, M., Sawa, S., Langa, F., Varona, R., Riethmacher, D. et al., In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J. Exp. Med. 2008. 205: 13811393.
  • 28
    Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V. and Segal, B. M., IL12- and IL23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008. 205: 15351541.
  • 29
    Hirata, S., Matsuyoshi, H., Fukuma, D., Kurisaki, A., Uemura, Y., Nishimura, Y. and Senju, S., Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL. J. Immunol. 2007. 178: 918925.
  • 30
    Varona, R., Villares, R., Carramolino, L., Goya, I., Zaballos, A., Gutierrez, J., Torres, M. et al., CCR6-deficient mice have impaired leucocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J. Clin. Invest. 2001. 107: 3745.
  • 31
    Huang, D., Tani, M., Wang, J., Han, Y., He, T. T., Weaver, J., Charo, I. F. et al., Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. J. Neurosci. 2002. 22: 1063310642.